Skip to main content
Clinical Trials/ACTRN12620001018909
ACTRN12620001018909Completed未知

nderstanding dyspnoea and exercise limitation in interstitial lung disease: the role of skeletal muscle afferents (sub-study 3)

niversity of Auckland0 sites32 target enrollmentStarted: October 7, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
32

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Patients with fibrotic ILD (total lung capacity <80% predicted; FEV1/FVC > 0.7 and standard HRCT criteria (British Thoracic Society guidelines, 2008)
  • Control participants free from fibrotic ILD
  • Men and women
  • Aged 18 years or over

Exclusion Criteria

  • More than 10 pack year smoking history
  • Evidence of emphysema on CT scan
  • Pulmonary Sarcoidosis
  • Currently taking regular inhaled therapy for airways disease
  • Serious co-morbidities that may contribute to dyspnoea and/or reduce exercise capacity including:
  • oSevere respiratory disease other than ILD (e.g., chronic obstructive pulmonary disease)
  • oPulmonary hypertension
  • oSevere obesity (Body mass index > 35 kg/m2)
  • oSevere orthopaedic impairment or rheumatologic disease
  • oSignificant neurological disease
  • oInfection or pyrexial illness
  • Presence of any contraindications to cardiopulmonary exercise testing (as per American Thoracic Society/American College of Chest Physicians Statement on Cardiopulmonary Exercise Testing, 2003)
  • oUnstable angina or recent acute myocardial infarction
  • oUncontrolled arrhythmias causing symptoms or haemodynamic compromise
  • oSymptomatic severe aortic stenosis
  • oOxygen saturation <85% at rest on room air
  • oUncontrolled heart failure
  • oUncontrolled asthma
  • oUncontrolled thyroid disorders
  • oMental impairment leading to inability to cooperate
  • Current pregnancy
  • Current users of recreational drugs
  • Current abusers of alcohol
  • Inability to fully or appropriately provide consent (e.g., language issue, reading capability)
  • Underlying medical conditions, which in the opinion of the Investigator place the participant at unacceptably high risk for participating in the study.

Investigators

Sponsor
niversity of Auckland

Similar Trials

nderstanding breathlessness in... | Clinical Trial